Hadas Tamar Pahima, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mast Cells | 5 | 2023 | 1392 | 0.810 |
Why?
|
| Peritonitis | 1 | 2021 | 368 | 0.640 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1409 | 0.530 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 731 | 0.440 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 3 | 2024 | 35 | 0.390 |
Why?
|
| Ovalbumin | 3 | 2023 | 675 | 0.250 |
Why?
|
| Staphylococcus aureus | 3 | 2023 | 1457 | 0.250 |
Why?
|
| Asthma | 2 | 2021 | 6233 | 0.250 |
Why?
|
| Eosinophils | 2 | 2021 | 953 | 0.230 |
Why?
|
| Immunoglobulin E | 4 | 2023 | 1502 | 0.210 |
Why?
|
| Cromolyn Sodium | 1 | 2022 | 78 | 0.190 |
Why?
|
| Hypersensitivity | 3 | 2021 | 1167 | 0.180 |
Why?
|
| Respiratory System Agents | 1 | 2020 | 30 | 0.180 |
Why?
|
| Inflammation | 6 | 2023 | 10760 | 0.170 |
Why?
|
| Enterotoxins | 1 | 2021 | 366 | 0.170 |
Why?
|
| DNA, Mitochondrial | 1 | 2024 | 865 | 0.160 |
Why?
|
| Oxylipins | 1 | 2018 | 53 | 0.150 |
Why?
|
| Cyclopentanes | 1 | 2018 | 87 | 0.150 |
Why?
|
| Granulocytes | 1 | 2020 | 551 | 0.150 |
Why?
|
| Mitochondria | 3 | 2024 | 3619 | 0.150 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2018 | 95 | 0.150 |
Why?
|
| Keratosis, Actinic | 1 | 2018 | 72 | 0.140 |
Why?
|
| Immunization | 1 | 2021 | 1217 | 0.140 |
Why?
|
| Acetates | 1 | 2018 | 321 | 0.140 |
Why?
|
| Respiratory System | 1 | 2020 | 563 | 0.140 |
Why?
|
| Interleukin-10 | 1 | 2022 | 1172 | 0.130 |
Why?
|
| Apoptosis | 3 | 2024 | 9476 | 0.120 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 750 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 574 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1662 | 0.110 |
Why?
|
| Ultraviolet Rays | 1 | 2018 | 1079 | 0.110 |
Why?
|
| Animals | 10 | 2023 | 168201 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2013 | 982 | 0.070 |
Why?
|
| Mice | 7 | 2023 | 81368 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22115 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 5146 | 0.060 |
Why?
|
| Skin | 1 | 2018 | 4473 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9172 | 0.050 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2023 | 84 | 0.050 |
Why?
|
| eIF-2 Kinase | 1 | 2022 | 145 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18221 | 0.050 |
Why?
|
| Cytokines | 3 | 2021 | 7373 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 1884 | 0.040 |
Why?
|
| Calcium | 1 | 2013 | 5717 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5812 | 0.040 |
Why?
|
| Hexokinase | 1 | 2018 | 124 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2020 | 661 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2021 | 1336 | 0.030 |
Why?
|
| Humans | 11 | 2024 | 760617 | 0.030 |
Why?
|
| Chemokines | 1 | 2021 | 954 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2018 | 961 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13635 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 1748 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 835 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2023 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1654 | 0.030 |
Why?
|
| Calcimycin | 1 | 2013 | 213 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2013 | 102 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 295 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6188 | 0.020 |
Why?
|
| Models, Animal | 1 | 2018 | 2109 | 0.020 |
Why?
|
| Female | 4 | 2024 | 392148 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3599 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 1646 | 0.020 |
Why?
|
| Male | 3 | 2024 | 360358 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2812 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2022 | 23416 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5907 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 3087 | 0.020 |
Why?
|
| Wound Healing | 1 | 2018 | 2802 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2018 | 3045 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 15576 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3705 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16571 | 0.010 |
Why?
|
| Rats | 1 | 2018 | 23717 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15828 | 0.010 |
Why?
|
| Adult | 2 | 2024 | 220969 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 88234 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 220584 | 0.010 |
Why?
|